NEW YORK, Feb. 28 2022 (GLOBE NEWSWIRE) — Valuence Merger Corp. I (the “Company”), a newly incorporated blank check company incorporated as a Cayman Islands exempt company, today announced the pricing for its initial public offering of 20,000,000 units at the price of 10, $00 each. The units will be listed on the Nasdaq Global Market (“Nasdaq”) and are expected to trade under the symbol “VMCAU” beginning March 1, 2022. Each unit consists of one Class A common share and one-half redeemable share. mandate of the Company. Each whole warrant entitles its holder to purchase one Class A common share of the Company at a price of $11.50 per share. Once the securities comprising the Units begin trading separately, the Shares and Warrants are expected to trade on NASDAQ under the symbols “VMCA” and “VMCAW”, respectively. The offering is expected to close on March 3, 2022, subject to customary closing conditions.
SVB Leerink is acting as sole bookrunner for the offering, and Baird is acting as lead manager for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,000,000 units at the initial public offering price to cover over-allotments, if any.
A registration statement relating to the securities was declared effective by the United States Securities and Exchange Commission (the “SEC”) on February 28, 2022. The offering is being made by way of prospectus only. When available, copies of the prospectus may be obtained by contacting SVB Securities LLC, Attention: Syndicate Department, 53 State Street, 40th Floor, Boston, Massachusetts 02109, by telephone at 1-800-808-7525, ext. 6105, or by email at syndicate@svbleerink.com, or by visiting EDGAR on the SEC’s website at www.sec.gov.
This press release does not constitute an offer to sell or the solicitation of an offer to buy, and there will be no sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful. prior to registration or qualification under the securities laws of such state or territory.
About Valuence Merger Corp. I
Valuence Merger Corp. I is a blank check corporation formed for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses . The team’s objective is to identify, merge and partner with a business in Asia (excluding China, Hong Kong and Macao) with a particular focus on advanced technologies in life sciences and/ or sustainable technologies. The management team is led by Sung Yoon Woo, Andrew Hyung, Sung Lee, and Gene Cho. The Company plans to collaborate with CrystalBioSciences, a life sciences-focused venture capital firm, Credian Partners, a South Korea-based private equity firm, and Quantum Leaps, a Japan-based consulting firm that has was founded by Mr. Nobuyuki Idei, a former CEO and Chairman of Sony.
Forward-looking statements
This press release contains statements that constitute “forward-looking statements”, including with respect to the proposed initial public offering and the intended use of net proceeds thereof and with respect to any business combination or acquisition opportunity. No guarantee can be given that the offer described above will be carried out on the terms described, or not at all, or that the net proceeds of the offer will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the Company’s control, including those set forth in the Risk Factors section of the Company’s registration statement and the Company’s filed preliminary offering prospectus. with the SEC. Copies of these documents are available on the SEC’s website, www.sec.gov. The Company assumes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
contacts:
Sung Yoon Woo
CEO, Valuence Merger Corp. I
(415) 340-0222
Email: IR@valuecap.com